(HM-B) H & M Hennes & Mauritz - Ratings and Ratios
Clothing, Accessories, Footwear, Cosmetics, Homeware, Textiles
HM-B EPS (Earnings per Share)
HM-B Revenue
Description: HM-B H & M Hennes & Mauritz
H&M Hennes & Mauritz AB (publ) is a global fashion retailer offering a wide range of clothing, accessories, footwear, cosmetics, and home textiles under multiple brand names, including H&M, COS, and ARKET. The companys diverse product portfolio caters to women, men, and children, with a focus on fashion, quality, and sustainability.
The companys business model is multifaceted, with both online and physical stores, as well as a growing presence in second-hand fashion through its Sellpy platform. Additionally, H&M has invested in sustainable practices, such as garment collecting and recycling under the Looper Textile initiative, and has introduced seasonal vegetarian cafés and coffee shops.
Key performance indicators (KPIs) for H&M include revenue growth, gross margin, and sales per square meter. The company has been working to improve its online sales, which currently account for a significant portion of its revenue. Other important metrics include customer satisfaction, brand awareness, and inventory turnover. With a strong brand presence in over 70 countries, H&Ms ability to adapt to changing consumer trends and preferences will be crucial to its future success.
From a financial perspective, H&Ms market capitalization is approximately 220 billion SEK, with a price-to-earnings ratio of 22.02 and a forward P/E of 20.58. The companys return on equity (RoE) is 23.20%, indicating a relatively strong profitability. To further evaluate the companys performance, metrics such as EBITDA margin, operating cash flow, and debt-to-equity ratio should be analyzed.
Overall, H&Ms diversified brand portfolio, commitment to sustainability, and omnichannel retail strategy position the company for continued growth and competitiveness in the global fashion market.
HM-B Stock Overview
Market Cap in USD | 24,008m |
Sub-Industry | Apparel, Accessories & Luxury Goods |
IPO / Inception |
HM-B Stock Ratings
Growth Rating | -20.7% |
Fundamental | 78.4% |
Dividend Rating | 60.0% |
Return 12m vs S&P 500 | -23.0% |
Analyst Rating | - |
HM-B Dividends
Dividend Yield 12m | 7.12% |
Yield on Cost 5y | 8.92% |
Annual Growth 5y | 0.00% |
Payout Consistency | 92.7% |
Payout Ratio | 107.1% |
HM-B Growth Ratios
Growth Correlation 3m | 51.5% |
Growth Correlation 12m | -77.4% |
Growth Correlation 5y | 9% |
CAGR 5y | 4.26% |
CAGR/Max DD 5y | 0.08 |
Sharpe Ratio 12m | -0.16 |
Alpha | -27.63 |
Beta | 0.820 |
Volatility | 30.67% |
Current Volume | 1248.7k |
Average Volume 20d | 1799.5k |
Stop Loss | 134.6 (-3.1%) |
Signal | -2.75 |
Piotroski VR‑10 (Strict, 0-10) 6.5
Net Income (9.97b TTM) > 0 and > 6% of Revenue (6% = 14.00b TTM) |
FCFTA 0.09 (>2.0%) and ΔFCFTA -6.42pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue -0.12% (prev 2.59%; Δ -2.71pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.17 (>3.0%) and CFO 27.92b > Net Income 9.97b (YES >=105%, WARN >=100%) |
Net Debt (40.15b) to EBITDA (37.84b) ratio: 1.06 <= 3.0 (WARN <= 3.5) |
Current Ratio 1.00 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (1.60b) change vs 12m ago -0.38% (target <= -2.0% for YES) |
Gross Margin 52.59% (prev 46.69%; Δ 5.90pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 134.0% (prev 131.8%; Δ 2.28pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 7.10 (EBITDA TTM 37.84b / Interest Expense TTM 2.23b) >= 6 (WARN >= 3) |
Altman Z'' 1.68
(A) -0.00 = (Total Current Assets 72.46b - Total Current Liabilities 72.74b) / Total Assets 168.29b |
(B) 0.23 = Retained Earnings (Balance) 39.49b / Total Assets 168.29b |
(C) 0.09 = EBIT TTM 15.80b / Avg Total Assets 174.02b |
(D) 0.30 = Book Value of Equity 39.70b / Total Liabilities 131.77b |
Total Rating: 1.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 78.39
1. Piotroski 6.50pt = 1.50 |
2. FCF Yield 6.73% = 3.37 |
3. FCF Margin 6.80% = 1.70 |
4. Debt/Equity 0.64 = 2.30 |
5. Debt/Ebitda 0.61 = 2.22 |
6. ROIC - WACC 17.10% = 12.50 |
7. RoE 23.20% = 1.93 |
8. Rev. Trend -10.74% = -0.54 |
9. Rev. CAGR -0.47% = -0.08 |
10. EPS Trend 39.52% = 0.99 |
11. EPS CAGR 26.47% = 2.50 |
What is the price of HM-B shares?
Over the past week, the price has changed by -4.34%, over one month by +4.75%, over three months by +1.13% and over the past year by -9.96%.
Is H & M Hennes & Mauritz a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HM-B is around 132.13 SEK . This means that HM-B is currently overvalued and has a potential downside of -4.84%.
Is HM-B a buy, sell or hold?
What are the forecasts/targets for the HM-B price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 134.4 | -3.2% |
Analysts Target Price | - | - |
ValueRay Target Price | 147.2 | 6% |
HM-B Fundamental Data Overview
Market Cap SEK = 228.64b (228.64b SEK * 1.0 SEK.SEK)
CCE Cash And Equivalents = 16.26b SEK (last quarter)
P/E Trailing = 23.187
P/E Forward = 16.8067
P/S = 0.9802
P/B = 6.2685
P/EG = 1.924
Beta = 1.131
Revenue TTM = 233.25b SEK
EBIT TTM = 15.80b SEK
EBITDA TTM = 37.84b SEK
Long Term Debt = 11.39b SEK (from longTermDebt, last quarter)
Short Term Debt = 11.81b SEK (from shortTermDebt, last quarter)
Debt = 23.21b SEK (Calculated: Short Term 11.81b + Long Term 11.39b)
Net Debt = 40.15b SEK (from netDebt column, last quarter)
Enterprise Value = 235.59b SEK (228.64b + Debt 23.21b - CCE 16.26b)
Interest Coverage Ratio = 7.10 (Ebit TTM 15.80b / Interest Expense TTM 2.23b)
FCF Yield = 6.73% (FCF TTM 15.87b / Enterprise Value 235.59b)
FCF Margin = 6.80% (FCF TTM 15.87b / Revenue TTM 233.25b)
Net Margin = 4.27% (Net Income TTM 9.97b / Revenue TTM 233.25b)
Gross Margin = 52.59% ((Revenue TTM 233.25b - Cost of Revenue TTM 110.58b) / Revenue TTM)
Tobins Q-Ratio = 5.93 (Enterprise Value 235.59b / Book Value Of Equity 39.70b)
Interest Expense / Debt = 2.68% (Interest Expense 623.0m / Debt 23.21b)
Taxrate = 24.99% (from yearly Income Tax Expense: 3.86b / 15.44b)
NOPAT = 11.85b (EBIT 15.80b * (1 - 24.99%))
Current Ratio = 1.00 (Total Current Assets 72.46b / Total Current Liabilities 72.74b)
Debt / Equity = 0.64 (Debt 23.21b / last Quarter total Stockholder Equity 36.52b)
Debt / EBITDA = 0.61 (Net Debt 40.15b / EBITDA 37.84b)
Debt / FCF = 1.46 (Debt 23.21b / FCF TTM 15.87b)
Total Stockholder Equity = 42.97b (last 4 quarters mean)
RoA = 5.92% (Net Income 9.97b, Total Assets 168.29b )
RoE = 23.20% (Net Income TTM 9.97b / Total Stockholder Equity 42.97b)
RoCE = 29.07% (Ebit 15.80b / (Equity 42.97b + L.T.Debt 11.39b))
RoIC = 25.49% (NOPAT 11.85b / Invested Capital 46.50b)
WACC = 8.39% (E(228.64b)/V(251.85b) * Re(9.04%)) + (D(23.21b)/V(251.85b) * Rd(2.68%) * (1-Tc(0.25)))
Shares Correlation 5-Years: -100.0 | Cagr: -0.77%
Discount Rate = 9.04% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 71.91% ; FCFE base≈20.91b ; Y1≈17.87b ; Y5≈13.84b
Fair Price DCF = 151.1 (DCF Value 212.91b / Shares Outstanding 1.41b; 5y FCF grow -17.69% → 3.0% )
Revenue Correlation: -10.74 | Revenue CAGR: -0.47%
Rev Growth-of-Growth: -3.05
EPS Correlation: 39.52 | EPS CAGR: 26.47%
EPS Growth-of-Growth: -91.44